Ulipristal acetate for the management of acute heavy menstrual bleeding without fibroids

Heavy menstrual bleeding is a common condition among women of childbearing age. Although hysterectomy was the usual approach in acute cases in the past, other minimally invasive therapies or pharmacological alternatives, such as the levonorgestrel intrauterine device have shown to be highly effectiv...

Full description

Saved in:
Bibliographic Details
Published in:Gynecological endocrinology 2018-07, Vol.34 (7), p.554-557
Main Authors: Estadella, Josep, Español, Pia, Ascencio, Fiorella, Perelló, Josep, Calaf, Joaquim
Format: Article
Language:English
Subjects:
Acute Disease
Adult
Female
Humans
Menorrhagia - drug therapy
Norpregnadienes - therapeutic use
Treatment Outcome
Uterine Hemorrhage - drug therapy
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Heavy menstrual bleeding is a common condition among women of childbearing age. Although hysterectomy was the usual approach in acute cases in the past, other minimally invasive therapies or pharmacological alternatives, such as the levonorgestrel intrauterine device have shown to be highly effective. This case report presents the case of a pluripathological patient with acute heavy menstrual bleeding and severe anemia, who was successfully managed with ulipristal acetate, a selective progesterone receptor modulator. Bleeding control was achieved in 6 d without side effects, avoiding the need for surgery. This report suggests that ulipristal acetate could be useful in the treatment of acute uterine bleeding even in a structurally normal uterus without fibroids.
ISSN:0951-3590
1473-0766
DOI:10.1080/09513590.2017.1417376